These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 38723736)
1. Elevated extracellular vesicular Nm23-H1 subdues the pro-migratory potential of breast cancer cell-derived extracellular vesicles. Saini V; Do Y; Yam JWP; Wong YH Cell Signal; 2024 Aug; 120():111203. PubMed ID: 38723736 [TBL] [Abstract][Full Text] [Related]
2. CTCF and EGR1 suppress breast cancer cell migration through transcriptional control of Nm23-H1. Wong KM; Song J; Wong YH Sci Rep; 2021 Jan; 11(1):491. PubMed ID: 33436746 [TBL] [Abstract][Full Text] [Related]
3. Mutations at the dimer interface and surface residues of Nm23-H1 metastasis suppressor affect its expression and function. Li Y; Liu W; Saini V; Wong YH Mol Cell Biochem; 2020 Nov; 474(1-2):95-112. PubMed ID: 32705629 [TBL] [Abstract][Full Text] [Related]
4. Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds. Ouatas T; Halverson D; Steeg PS Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3763-72. PubMed ID: 14506169 [TBL] [Abstract][Full Text] [Related]
5. Nm23-h1 binds to gelsolin and inactivates its actin-severing capacity to promote tumor cell motility and metastasis. Marino N; Marshall JC; Collins JW; Zhou M; Qian Y; Veenstra T; Steeg PS Cancer Res; 2013 Oct; 73(19):5949-62. PubMed ID: 23940300 [TBL] [Abstract][Full Text] [Related]
6. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer. Palmieri D; Halverson DO; Ouatas T; Horak CE; Salerno M; Johnson J; Figg WD; Hollingshead M; Hursting S; Berrigan D; Steinberg SM; Merino MJ; Steeg PS J Natl Cancer Inst; 2005 May; 97(9):632-42. PubMed ID: 15870434 [TBL] [Abstract][Full Text] [Related]
7. Extracellular Vesicle-Mediated Purinergic Signaling Contributes to Host Microenvironment Plasticity and Metastasis in Triple Negative Breast Cancer. Duan S; Nordmeier S; Byrnes AE; Buxton ILO Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435297 [TBL] [Abstract][Full Text] [Related]
8. Nm23-H1 metastasis suppressor expression level influences the binding properties, stability, and function of the kinase suppressor of Ras1 (KSR1) Erk scaffold in breast carcinoma cells. Salerno M; Palmieri D; Bouadis A; Halverson D; Steeg PS Mol Cell Biol; 2005 Feb; 25(4):1379-88. PubMed ID: 15684389 [TBL] [Abstract][Full Text] [Related]
9. Interaction of the tumor metastasis suppressor nonmetastatic protein 23 homologue H1 and estrogen receptor alpha alters estrogen-responsive gene expression. Curtis CD; Likhite VS; McLeod IX; Yates JR; Nardulli AM Cancer Res; 2007 Nov; 67(21):10600-7. PubMed ID: 17975005 [TBL] [Abstract][Full Text] [Related]
10. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2. Horak CE; Lee JH; Elkahloun AG; Boissan M; Dumont S; Maga TK; Arnaud-Dabernat S; Palmieri D; Stetler-Stevenson WG; Lacombe ML; Meltzer PS; Steeg PS Cancer Res; 2007 Aug; 67(15):7238-46. PubMed ID: 17671192 [TBL] [Abstract][Full Text] [Related]
11. A novel function for the nm23-H1 gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest. Howlett AR; Petersen OW; Steeg PS; Bissell MJ J Natl Cancer Inst; 1994 Dec; 86(24):1838-44. PubMed ID: 7990158 [TBL] [Abstract][Full Text] [Related]
12. Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells. Boissan M; De Wever O; Lizarraga F; Wendum D; Poincloux R; Chignard N; Desbois-Mouthon C; Dufour S; Nawrocki-Raby B; Birembaut P; Bracke M; Chavrier P; Gespach C; Lacombe ML Cancer Res; 2010 Oct; 70(19):7710-22. PubMed ID: 20841469 [TBL] [Abstract][Full Text] [Related]
13. Differential regulation of NM23-H1 under hypoxic and serum starvation conditions in metastatic cancer cells and its implication in EMT. Rasool RU; Nayak D; Chakraborty S; Jamwal VL; Mahajan V; Katoch A; Faheem MM; Iqra Z; Amin H; Gandhi SG; Goswami A Eur J Cell Biol; 2017 Mar; 96(2):164-171. PubMed ID: 28216015 [TBL] [Abstract][Full Text] [Related]
14. Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition. Hartsough MT; Clare SE; Mair M; Elkahloun AG; Sgroi D; Osborne CK; Clark G; Steeg PS Cancer Res; 2001 Mar; 61(5):2320-7. PubMed ID: 11280805 [TBL] [Abstract][Full Text] [Related]
15. Nm23-H1 promotes adhesion of CAL 27 cells in vitro. Bago R; Pavelić J; Maravić Vlahovicek G; Bosnar MH Mol Carcinog; 2009 Sep; 48(9):779-89. PubMed ID: 19263457 [TBL] [Abstract][Full Text] [Related]
16. Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2. Horak CE; Mendoza A; Vega-Valle E; Albaugh M; Graff-Cherry C; McDermott WG; Hua E; Merino MJ; Steinberg SM; Khanna C; Steeg PS Cancer Res; 2007 Dec; 67(24):11751-9. PubMed ID: 18089805 [TBL] [Abstract][Full Text] [Related]
17. Caveolin-1-containing extracellular vesicles transport adhesion proteins and promote malignancy in breast cancer cell lines. Campos A; Salomon C; Bustos R; Díaz J; Martínez S; Silva V; Reyes C; Díaz-Valdivia N; Varas-Godoy M; Lobos-González L; Quest AF Nanomedicine (Lond); 2018 Oct; 13(20):2597-2609. PubMed ID: 30338706 [TBL] [Abstract][Full Text] [Related]
18. Correlation of NM23-H1 cytoplasmic expression with metastatic stage in human prostate cancer tissue. Andolfo I; De Martino D; Liguori L; Petrosino G; Troncone G; Tata N; Galasso A; Roma C; Chiancone F; Zarrilli S; Arrigoni G; Staibano S; Imbimbo C; Zollo M Naunyn Schmiedebergs Arch Pharmacol; 2011 Oct; 384(4-5):489-98. PubMed ID: 21553004 [TBL] [Abstract][Full Text] [Related]
19. c-Abl and Arg induce cathepsin-mediated lysosomal degradation of the NM23-H1 metastasis suppressor in invasive cancer. Fiore LS; Ganguly SS; Sledziona J; Cibull ML; Wang C; Richards DL; Neltner JM; Beach C; McCorkle JR; Kaetzel DM; Plattner R Oncogene; 2014 Sep; 33(36):4508-4520. PubMed ID: 24096484 [TBL] [Abstract][Full Text] [Related]